Searchable abstracts of presentations at key conferences in endocrinology

ea0085p76 | Obesity 2 | BSPED2022

Semaglutide as a safe and effective weight loss treatment in children with obesity

van Boxel Elizabeth , Boulos Nabil , Jayne Kathryn , Reilly Joseph , Mayes Rebecca , Davis Nikki

Background: A quarter of UK children now leave primary school obese. Childhood obesity is associated with significant comorbidity including obstructive sleep apnoea, type 2 diabetes, non-alcoholic fatty liver disease, hypertension and depression. We report our experience of using semaglutide, a weekly subcutaneous GLP1 receptor agonist, as a weight-loss adjunct for severely obese children in combination with dietary and lifestyle support from a multidisciplinary team.<p cl...